可比性
神经康复
物理医学与康复
物理疗法
可靠性(半导体)
冲程(发动机)
一致性(知识库)
国际功能、残疾和健康分类
联营
康复
医学
心理学
临床试验
梅德林
批判性评价
严厉
随机对照试验
运动训练
过程(计算)
循证医学
循证实践
研究设计
等级间信度
医学物理学
最小临床重要差异
功能性运动
概化理论
应用心理学
手法治疗
运动功能
功能(生物学)
作业疗法
系统回顾
克朗巴赫阿尔法
作者
Julie Hervé-Colas,Sarah Newton,Stefan T. Engelter,Kathryn S. Hayward,Jeremia P. O. Held,Nadine Intering,Gert Kwakkel,Johannes Pohl,Darcy S. Reisman,Anne Schwarz,Katharina Stibrant Sunnerhagen,Janne Marieke Veerbeek,Karin Wiesner,Sarah B. Zandvliet,Margit Alt Murphy
标识
DOI:10.1177/15459683251412300
摘要
BackgroundFugl-Meyer Assessment of upper and lower extremity is the recommended primary clinical outcome measure of motor function in stroke rehabilitation. However, variations between different manuals undermine the reliability of the assessment, making it difficult to compare results and pool data across trials and centers.ObjectiveTo develop a consensus-based international Fugl-Meyer Assessment (FMA) manual aligned with the original assessment along with agreed recommendations for assessor training. Additionally, the study aims to provide a critical review of current evidence on the measurement properties.MethodsFourteen experienced health professionals and expert FMA users, working in 3 different continents, 6 countries and 13 research centers, participated in an iterative consensus process to generate a comprehensive agreed FMA manual. Agreement of at least 75% determined by voting was the minimum accepted threshold for each section of the manual. Consensus on assessor training was also sought. The evidence on measurement properties was compiled through a systematic literature review.ResultsGreater than 79% agreement was reached for each section of the final FMA manual. Assessors should have strong foundation in neurorehabilitation and clinical assessment. Novice assessors should undergo structured training including supervised practical training with patients to ensure consistent and accurate scoring. Previous research adherent to the original FMA assessment, confirms strong validity and reliability, but provide limited information of minimal clinically important difference thresholds.ConclusionsThis internationally agreed manual provides a common ground for improved consistency in administration of FMA worldwide and thereby will enable reliable data pooling and increase the comparability of results in future trials and clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI